Lineage Cell Therapeutics Inc (AMEX:LCTX)
$ 1.03 -0.02 (-1.9%) Market Cap: 194.49 Mil Enterprise Value: 156.01 Mil PE Ratio: 0 PB Ratio: 2.71 GF Score: 75/100

Q4 2019 Lineage Cell Therapeutics Inc Earnings Call Transcript

Mar 12, 2020 / 08:30PM GMT
Release Date Price: $0.6801 (-14.10%)
Operator

Ladies and gentlemen, welcome to the Lineage Therapeutics Fourth Quarter and Full Year 2019 Financial Results Earnings Call. (Operator Instructions)

An audio webcast of this call is available on the Investors section of Lineage website at www.lineagecell.com. This call is subject to copyright and is the property of Lineage. And recordings, reproduction or transmission of this call without the expressed written consent of Lineage are strictly prohibited. As a reminder, today's call is being recorded.

I would now like to introduce your host for today's conference, Ioana Hone, Director of Investor Relations at Lineage. Ms. Hone, you may begin.

Ioana C. Hone
Lineage Cell Therapeutics, Inc. - Director of IR

Thank you, Howard. Good afternoon and thank you for joining us. A press release reporting our fourth quarter and full year 2019 financial results was issued earlier today, March 12, 2020, and can be found on the Investors section of our website.

Please note that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot